Healthcare Sales & Marketing Network News: amyloid

Searching News Database: amyloid

HSMN NewsFeed - 8 Jan 2025
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 15 Apr 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Diagnostics Neurology Product Launch

HSMN NewsFeed - 8 Mar 2024
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 11 Oct 2023
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Diagnostics Neurology Product Launch

HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 29 Dec 2021
Ionis and AstraZeneca close deal to develop and commercialize eplontersen
Biopharmaceuticals

HSMN NewsFeed - 8 Dec 2021
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
Biopharmaceuticals Neurology Venture Capital Personnel

HSMN NewsFeed - 5 Aug 2021
KalGene Pharmaceuticals Inc. an Alzheimer's focused company using a next generation engineered drug candidate, has appointed new leadership
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 12 Jul 2021
Janssen Announces U.S. FDA Approval of DARZALEX FASPRO(R) (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 24 Jun 2021
Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 5 Apr 2021
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Feb 2021
New Scientific Publications Show Diadem's Blood-Based AlzoSure(R) Biomarker Test Can Predict Which Patients Will Progress to Alzheimer's Disease Years Before Symptoms Occur
Diagnostics Neurology

HSMN NewsFeed - 4 Jan 2021
Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team
Diagnostics Neurology Personnel

HSMN NewsFeed - 14 Sep 2020
Attralus Launches with $25 Million Series A Financing from venBio Partners to Transform Treatment for Patients with Systemic Amyloidosis
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 31 Aug 2020
Ionis Pharmaceuticals to acquire remaining stake in Akcea Therapeutics
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
Regenerative Medicine Neurology

HSMN NewsFeed - 13 May 2020
Optina Diagnostics receives 510(k) clearance from U.S. FDA for its MHRC-C1, permitting hyperspectral imaging of the retina
Devices Ophthalmology FDA

HSMN NewsFeed - 17 Apr 2020
PTC Therapeutics Announces New Leadership Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Feb 2020
Lilly Announces Topline Results for Solanezumab from the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Biopharmaceuticals Drug Delivery Endocrinology

HSMN NewsFeed - 9 Jan 2020
Ionis Appoints Onaiza Cadoret-Manier As Chief Corporate Development and Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 7 Nov 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 15 Apr 2019
EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 12 Dec 2018
Lilly and AC Immune Announce License and Collaboration Agreement
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 20 Sep 2018
Dr. Jared Gollob Joins Kymera Therapeutics as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Aug 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Biopharmaceuticals Neurology

HSMN NewsFeed - 6 Jul 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 5 Jul 2018
New England Journal of Medicine Publishes Results from Pivotal Study of TEGSEDI(TM) (inotersen) for the Treatment of Hereditary ATTR Amyloidosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Jun 2018
Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Apr 2018
Eidos Therapeutics completes $64M Series B financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Mar 2018
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Nov 2017
Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
Biopharmaceuticals Licensing

HSMN NewsFeed - 7 Nov 2017
Ionis Announces Management Transitions
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2017
SPINRAZA(R) (nusinersen) Approved in the European Union
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 May 2017
Ionis Pharmaceuticals Announces Phase 3 NEURO-TTR Study of Inotersen (IONIS-TTR Rx) Meets Both Primary Endpoints
Biopharmaceuticals

HSMN NewsFeed - 1 May 2017
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Feb 2017
CHMP Issues Positive Opinion Recommending DARZALEX(R) (daratumumab) for Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Dec 2016
Lilly and AstraZeneca to Develop Second Potentially Disease-Modifying Treatment for Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 Dec 2016
Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer's Disease (CTAD) 2016 Meeting
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Nov 2016
Conditional Approval from the European Commission to Treat Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 23 Nov 2016
Neurotrope Issues Statement On Eli Lilly's Solanezumab
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Nov 2016
Lilly Announces Top-Line Results of Solanezumab Phase 3 Clinical Trial
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Nov 2016
FDA Grants Fast Track Designation for Development of E2609, Eisai's BACE Inhibitor for Early Alzheimer's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 28 Sep 2016
Dr. Daniel Alkon Appointed President of Neurotrope, Inc.
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Aug 2016
Takeda Receives Marketing Authorization in Canada for NINLARO(TM) (ixazomib) in Relapsed/Refractory Multiple Myeloma
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Aug 2016
Neurotrope Announces Changes to the Board of Directors and Management
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 21 Jun 2016
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Apr 2016
Novartis Receives Three FDA Breakthrough Therapy Designations for IlaristTo Treat Rare Types of Periodic Fever Syndromes
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Apr 2016
Eli Lilly and Company and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Mar 2016
Cairn Diagnostics Launches FDA-Approved Spirulina Gastric Emptying Breath Test for Gastroparesis
Diagnostics Gastroenterology Product Launch

HSMN NewsFeed - 15 Mar 2016
Lilly Announces Change to Primary Endpoint of EXPEDITION3 Study
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Mar 2016
Accera Appoints Ernest Wong, Ph.D., as Head of Corporate Development
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Regenerative Medicine Neurology Personnel

HSMN NewsFeed - 3 Feb 2016
ProMIS Neurosciences announces identification of a second novel therapeutic target for Alzheimer's disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jan 2016
Akcea Therapeutics Appoints Louis St. L. O'Dea as Chief Medical Officer
Biopharmaceuticals Cardiology Personnel

HSMN NewsFeed - 5 Jan 2016
Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 21 Oct 2015
Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 8 Apr 2015
Alzheon Announces $10 Million Series A Financing
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Jan 2015
NeuroPhage Expands Series D Financing To $27 Million
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 6 Jan 2015
Isis Pharmaceuticals Appoints Paula Soteropoulos As President And Chief Executive Officer Of Akcea Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Nov 2014
NeuroPhage Appoints Industry Veteran Franz Hefti, PhD, President/COO
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Sep 2014
GE Healthcare Announces European Union Approval of VIZAMYL(TM) (Flutemetamol (18F) Solution for Injection) for PET Imaging of Beta Amyloid Plaque in Suspected Alzheimer’s Disease
Biopharmaceuticals Devices Radiology Oncology Regulatory

HSMN NewsFeed - 5 Aug 2014
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 Jun 2014
CHMP Recommends EU Approval of VIZAMYL(TM) (Flutemetamol F18 Injection) for PET Imaging of Beta Amyloid Plaque
Biopharmaceuticals Radiology Neurology Regulatory

HSMN NewsFeed - 25 Mar 2014
NeuroPhage, Inc. Raises $17 Million In Series D Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Jan 2014
Chelsea Therapeutics Names Keith W. Schmidt Chief Commercial Officer
Biopharmaceuticals Neurology Personnel

HSMN NewsFeed - 27 Jan 2014
Chelsea Therapeutics Announces Joseph G. Oliveto Named President and Chief Executive Officer, Director
Biopharmaceuticals Neurology Cardiology Personnel

HSMN NewsFeed - 25 Jan 2014
Amorfix Announces Retirement of Walter von Wartburg
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jan 2014
Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
Biopharmaceuticals Licensing

HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 May 2013
NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 12 Dec 2012
Lilly Provides Update on Next Steps for Solanezumab
Biopharmaceuticals Neurology

HSMN NewsFeed - 24 Aug 2012
Eli Lilly and Company Announces Top-Line Results on Solanezumab Phase 3 Clinical Trials in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2012
Cardinal Health to Manufacture, Distribute Eli Lilly and Company's Brain Imaging Agent Amyvid(TM) (Florbetapir F 18 Injection)
Biopharmaceuticals Radiology Neurology

HSMN NewsFeed - 23 Apr 2012
Nephros Appoints John C. Houghton as President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 23 Apr 2012
Oligomerix, Inc. Completes $2 Million Series A Financing
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 9 Apr 2012
DA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline
Biopharmaceuticals Radiology Neurology FDA

HSMN NewsFeed - 23 Feb 2012
Satori Pharmaceuticals Raises $15M in New Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Feb 2012
FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Nov 2011
Pfizer’s Vyndaqel(R) (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 29 Jun 2011
Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
Biopharmaceuticals Litigation

HSMN NewsFeed - 13 Jun 2011
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Apr 2011
Pfizer Receives Refusal To File Letter From U.S. FDA On Tafamidis New Drug Application
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Mar 2011
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 8 Feb 2011
Positron’s Attrius(R) PET Scanner Seeks Market Expansion into Neurologic Imaging
Devices Radiology Neurology

HSMN NewsFeed - 14 Jan 2011
GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology

HSMN NewsFeed - 9 Dec 2010
Alnylam Elects Marsha Fanucci to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Nov 2010
Lilly to Acquire Avid Radiopharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 8 Sep 2010
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's Treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 17 Aug 2010
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Aug 2010
Alectos Therapeutics Announces Collaboration With Merck to Develop Drugs for Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 10 Aug 2010
Avid Radiopharmaceuticals Expands R&D Capabilities with Appointment of Dr. Mark A. Mintun as Chief Medical Officer
Biopharmaceuticals Radiology Neurology Personnel

HSMN NewsFeed - 22 Jun 2010
Ipsen: Encouraging results of GuidAge(R), large scale European trial conducted in the prevention of Alzheimer's Dementia
Biopharmaceuticals Neurology

HSMN NewsFeed - 16 Jun 2010
Massachusetts General Hospital and QR Pharma Start a Collaboration on Posiphen(R) and Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Jun 2010
QR Pharma Completes $2.4 Million Seed Financing with Round-Closing Investments from BioAdvance and Angels to Advance Clinical Development of two Alzheimer's Disease Compounds
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 2 Jun 2010
Alnylam Strengthens Management Team with New Key Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 May 2010
FoldRx Pharmaceuticals Appoints Dr. Georges Gemayel as Executive Chairman
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Apr 2010
Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals

HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 30 Nov 2009
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Biopharmaceuticals Devices Radiology Neurology

HSMN NewsFeed - 2 Jul 2009
Nephros Receives 510k Approval for Dual Stage Ultrafilters
Devices FDA

HSMN NewsFeed - 9 Jun 2009
William Aliski Named FoldRx Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2009
Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing
Biopharmaceuticals Radiology Neurology Venture Capital

HSMN NewsFeed - 24 Feb 2009
Nephros Provides Update on 510k Applications
Devices FDA

HSMN NewsFeed - 21 Jan 2009
Alnylam and Collaborators at Harvard Medical School Demonstrate In Vivo Silencing of Key Genes Implicated in the Transmission of Herpes Simplex Virus-2 (HSV-2)
Biopharmaceuticals

HSMN NewsFeed - 20 Jan 2009
Alnylam Provides Update on Kreutzer-Limmer Patent Family
Biopharmaceuticals

HSMN NewsFeed - 3 Nov 2008
NxStage(R) Achieves Milestone with 3,000 End-Stage Renal Disease Patients Receiving Daily Home Hemodialysis Therapy
Devices

HSMN NewsFeed - 3 Oct 2008
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 1 Oct 2008
Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound
Biopharmaceuticals Neurology

HSMN NewsFeed - 17 Sep 2008
Nephros Appoints James S. Scibetta as Chairman of Board of Directors
Devices Personnel

HSMN NewsFeed - 17 Sep 2008
Nephros Appoints Ernest A. Elgin III as President and Chief Executive Officer
Devices Personnel

HSMN NewsFeed - 30 Aug 2008
Monoclonal Antibody Sales to Almost Double in Coming Years
Biopharmaceuticals

HSMN NewsFeed - 1 Jul 2008
Avid Appoints Richard A. Baron as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 May 2008
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 21 Apr 2008
Nephros Strengthens Commercialization Team with Addition of Marketing Executive
Devices Personnel

HSMN NewsFeed - 31 Mar 2008
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 13 Mar 2008
Neurochem moves eprodisate (KIACTA(TM)) drug development program forward for Amyloid A amyloidosis
Biopharmaceuticals

HSMN NewsFeed - 7 Feb 2008
Chelsea Therapeutics Begins Patient Dosing in Pivotal Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension
Biopharmaceuticals

HSMN NewsFeed - 1 Feb 2008
Neuro-Hitech Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer's Disease Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Dec 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 20 Nov 2007
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
Devices Regulatory

HSMN NewsFeed - 20 Nov 2007
Nephros Appoints James S. Scibetta to Board of Directors
Devices Personnel

HSMN NewsFeed - 12 Nov 2007
FDA Accepts Chelsea Therapeutics' Investigational New Drug Application for Droxidopa
Biopharmaceuticals FDA

HSMN NewsFeed - 8 Nov 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 22 Oct 2007
Acumen Co-Founders Link Alzheimer's Cause to Insulin Resistance
Biopharmaceuticals Neurology

HSMN NewsFeed - 25 Sep 2007
Nephros Raises $12.7 Million in New Financing
Devices Venture Capital

HSMN NewsFeed - 28 Aug 2007
Neurochem provides information on cash position
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Aug 2007
Baxter and The Alzheimer's Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Aug 2007
Neuro-Hitech Announces the Appointment of Dr. Gary Shearman as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Aug 2007
European Commission Grants Chelsea Therapeutics Two Orphan Medicinal Product Designations for Droxidopa
Biopharmaceuticals Regulatory

HSMN NewsFeed - 8 Aug 2007
Victor P. Micati Joins OLIGOMERIX's Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 31 Jul 2007
OXiGENE Appoints Patricia Walicke, M.D., Ph.D. as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Jul 2007
Applied NeuroSolutions' P-Tau 231 Cerebrospinal Fluid Diagnostic Test Identified as a Reliable Biomarker for Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 24 Jul 2007
Neurochem granted Fast Track designation from U.S. FDA for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals FDA Neurology

HSMN NewsFeed - 17 Jul 2007
Neurochem receives approvable letter for eprodisate (KIACTA(TM)) for treatment of AA amyloidosis
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2007
Tramiprosate (ALZHEMED(TM)) North American Phase III clinical trial progress update
Biopharmaceuticals Neurology

HSMN NewsFeed - 21 Jun 2007
Neurochem receives third recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 19 Jun 2007
Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
Biopharmaceuticals Radiology

HSMN NewsFeed - 18 Jun 2007
CoMentis Receives FDA Clearance to Begin Human Clinical Trials for Its Disease-Modifying Alzheimer's Therapy
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Jun 2007
Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA(TM)) Treatment for Patients with Amyloid A (AA) Amyloidosis
Biopharmaceuticals

HSMN NewsFeed - 4 Jun 2007
PET/CT: The Best Test for Women With Ovarian Cancer
Devices Radiology Oncology

HSMN NewsFeed - 30 May 2007
Neuro-Hitech, Inc., Obtains Exclusive License to Combination Drugs for the Treatment of Alzheimer's Disease and Other Serious Neurological Disorders
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 21 May 2007
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 9 May 2007
Avid Radiopharmaceuticals Closes $26 Million Series C Financing
Biopharmaceuticals Radiology Neurology Venture Capital

HSMN NewsFeed - 23 Apr 2007
Prana Expands Senior Management Team with Appointment of Two US-based Pharmaceutical Executives
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Apr 2007
Neurochem's eprodisate (KIACTA(TM)) PDUFA date extended three months by FDA
Biopharmaceuticals FDA

HSMN NewsFeed - 20 Mar 2007
Myriad Genetics Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan(TM) in Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Mar 2007
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Biopharmaceuticals Radiology Neurology

HSMN NewsFeed - 5 Mar 2007
Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
Biopharmaceuticals Radiology Neurology

HSMN NewsFeed - 5 Mar 2007
Myriad Presents Additional Flurizan(TM) Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Feb 2007
Athenagen Announces Name Change to CoMentis
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Feb 2007
ALSP, Inc., Appoints Michael D. Pierschbacher as President/CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Feb 2007
Neurochem receives second recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 Feb 2007
NxStage(R) Medical and DaVita Announce Agreement for Home Hemodialysis Using the NxStage System One(TM)
Devices

HSMN NewsFeed - 1 Feb 2007
Anavex Life Sciences Corp. Outlines Its Central Nervous System (CNS) Portfolio of Novel Therapeutics
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 Feb 2007
Neurochem announcement regarding the completion of its North American phase III clinical trial for tramiprosate (ALZHEMED(TM)) for the treatment of Alzheimer's disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Jan 2007
Nephros Receives Conditional Approval from the FDA of Investigational Device Exemption Application
Devices FDA

HSMN NewsFeed - 19 Jan 2007
Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative Diseases
Biopharmaceuticals Radiology Licensing

HSMN NewsFeed - 21 Dec 2006
Potential Alzheimer's Disease Treatment Discovered in Wales, UK
Biopharmaceuticals Neurology

HSMN NewsFeed - 8 Dec 2006
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 7 Dec 2006
Genentech and AC Immune: Exclusive License Agreement
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 4 Dec 2006
Merck and Neuroptix Collaborate on Early Alzheimer's Diagnostics Using Laser Eye Scanning
Devices Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Nov 2006
Acumen Pharmaceuticals Announces Amended Agreement with Merck to Include Exclusive Diagnostic Rights
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Nov 2006
GE Healthcare Re-Imagines Radiology at RSNA Conference; Company Showcases Innovative Technologies That Enable ''Early Health'' Model of Care
Devices Radiology

HSMN NewsFeed - 17 Nov 2006
Neuro-Hitech Announces Agreement to Acquire Q-RNA, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions

HSMN NewsFeed - 6 Nov 2006
Neurochem receives recommendations from data safety monitoring boards to continue phase III clinical trials for tramiprosate (ALZHEMED(TM))
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Nov 2006
Tramiprosate (ALZHEMED(TM)) Phase II Clinical Results Published in Neurology
Biopharmaceuticals Neurology

HSMN NewsFeed - 23 Oct 2006
Multi-Center Study Concludes Nephros Mid-Dilution Hemodiafiltration Therapy Achieves Higher Clearance of Low Molecular Weight Proteins
Devices

HSMN NewsFeed - 16 Oct 2006
Neurochem submits a complete response to FDA approvable letter for KIACTA(TM)
Biopharmaceuticals

HSMN NewsFeed - 11 Oct 2006
Osta Announces Promising Clinical Results on Blood Tests for Parkinson's Disease & Alzheimer's Disease
Diagnostics Neurology

HSMN NewsFeed - 5 Oct 2006
Nephros Announces Positive Results of Clinical Study for Olpur MD190 Mid-Dilution Hemodiafiltration Filter
Devices

HSMN NewsFeed - 27 Sep 2006
Elan and Transition Therapeutics Inc. Announce Global Collaboration to Develop and Commercialize Alzheimer's Disease Drug AZD-103
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jul 2006
Myriad's 24-Month Study of Flurizan Demonstrates Significant Benefit in Alzheimer's Disease Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Jul 2006
Schering AG and Avid Radiopharmaceuticals to Develop Novel Approach for Early Diagnostic Imaging of Alzheimer's Disease
Biopharmaceuticals Radiology

HSMN NewsFeed - 1 Jun 2006
Avid RP Strengthens Its Drug and Business Development Capabilities with the Addition of Three Industry Veterans
Biopharmaceuticals Personnel

HSMN NewsFeed - 30 May 2006
FoldRx Pharmaceuticals Closes $43 Million Series B Financing
Biopharmaceuticals Venture Capital

Return to NewsFeed

Additional items found! 80

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 80 additional stories matching:
amyloid
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.